Skip to content
Call us: 1.866.928.0928
  • Click here for 2022 Conference Info
Dawson James Logo
  • ABOUT US
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • MANAGING PARTNERS
    • LOCATIONS
    • CAREERS
  • REG BI/CRS
  • DISCLOSURES
    • MSRB
    • IRA Contributions for 2023
  • SERVICES
    • INDIVIDUAL INVESTORS
    • INVESTMENT BANKING
    • RESEARCH
    • CAPITAL MARKETS
    • SYNDICATE
    • INSTITUTIONAL SALES & TRADING
    • INSURANCE
    • WEALTH MANAGEMENT
  • TRANSACTIONS
  • CAREERS
  • RESEARCH
  • CONFERENCES
    • 2022 CONFERENCE
    • 2021 CONFERENCE
    • 2019 CONFERENCE
    • 2018 CONFERENCE
    • 2017 CONFERENCE
    • Uplist BootCamp 2017
    • 2016 CONFERENCE
    • 2015 CONFERENCE
  • NEWS
  • CONTACT US
  • ABOUT US
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • MANAGING PARTNERS
    • LOCATIONS
    • CAREERS
  • REG BI/CRS
  • DISCLOSURES
    • MSRB
    • IRA Contributions for 2023
  • SERVICES
    • INDIVIDUAL INVESTORS
    • INVESTMENT BANKING
    • RESEARCH
    • CAPITAL MARKETS
    • SYNDICATE
    • INSTITUTIONAL SALES & TRADING
    • INSURANCE
    • WEALTH MANAGEMENT
  • TRANSACTIONS
  • CAREERS
  • RESEARCH
  • CONFERENCES
    • 2022 CONFERENCE
    • 2021 CONFERENCE
    • 2019 CONFERENCE
    • 2018 CONFERENCE
    • 2017 CONFERENCE
    • Uplist BootCamp 2017
    • 2016 CONFERENCE
    • 2015 CONFERENCE
  • NEWS
  • CONTACT US
Loading...
Report – PSTInerdadmin2022-08-17T08:28:47-04:00

Pluristem Therapeutics Inc.

Latest Publication

Termination Report 08/16/22
Rating Change Report 07/13/22
Company Update 05/10/22
Company Update 02/24/22
Company Update 01/10/22
Company Update 12/01/21
Company Update 07/08/21
Company Update 05/04/21
Company Update 12/09/20
Company Update 10/07/20
Company Update 09/15/20
Company Update 08/27/20
Company Update 08/10/20
Company Update 06/11/20
Company Update 05/14/20
Company Update 05/14/20
Company Update 05/08/20
Company Update 04/24/20
Company Update 04/14/20
Company Update 04/07/20
Company Update 03/30/20
Company Update 03/18/20
Company Update 03/12/20
Company Update 03/04/20
Company Update 02/10/20
Company Update 12/17/19
Initiation Report 12/16/19

  • Research Philosophy
  • Reports
  • Terminated Coverage
  • Sector Research
  • Appearances
  • Webinars


“To view Dawson James’ Business Continuity Plan please click here for more information.”

Please note our Corporate address has changed as of October 12, 2020.

Dawson James Securities Inc.
Member FINRA/SIPC
101 N. Federal Highway Suite 600 Boca Raton, Florida 33432
Privacy Pledge | Contact Us | Terms & Conditions | FINRA | SIPC | FINRA BrokerCheck | Fees | Disclosures | Rule 606 Reports | Client Login
Page load link

“To view Dawson James’ Business Continuity Plan amidst the COVID-19 crisis please click here for more information.”

Go to Top